Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label study of rVIII-SingleChain in previously treated Chinese patients with severe hemophilia A
CTR20244332Phase 3Active
- Sponsor
- CSL Limited
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lonoctocog alfa in hemophilia A, sponsored by CSL Limited. Started Jan 2025; status: active.
02
Drugs
lonoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20244332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244332.